A retrospective study of hepatitis B vaccination in preterm birth and low birth weight infants born to hepatitis B surface antigen-positive mothers: Time to close the policy-practice gap

National Immunization Program-version 2016 (ISIV-NIP-v2016) recommended a 4-dose hepatitis B vaccine (HepB) schedule for preterm birth (PTB) and low birth weight (LBW) infants born to HBsAg-positive mothers. However, the implementation of this immunization strategy in the past five years has not bee...

Full description

Bibliographic Details
Main Authors: Wei Qin, Yao Wang, Xiaqing Zhang, Fan Pan, Kai Cheng, Haitian Sui, Shaoyu Xie
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:http://dx.doi.org/10.1080/21645515.2022.2155390
_version_ 1797673146890846208
author Wei Qin
Yao Wang
Xiaqing Zhang
Fan Pan
Kai Cheng
Haitian Sui
Shaoyu Xie
author_facet Wei Qin
Yao Wang
Xiaqing Zhang
Fan Pan
Kai Cheng
Haitian Sui
Shaoyu Xie
author_sort Wei Qin
collection DOAJ
description National Immunization Program-version 2016 (ISIV-NIP-v2016) recommended a 4-dose hepatitis B vaccine (HepB) schedule for preterm birth (PTB) and low birth weight (LBW) infants born to HBsAg-positive mothers. However, the implementation of this immunization strategy in the past five years has not been fully evaluated in China. We reviewed the data of pregnant women and live-born infants from 24 hospitals between 2016 and 2021 in Lu’an, Anhui province, to estimate the prevalence of PTB, LBW, and hepatitis B virus (HBV) infected pregnant women. We analyzed the vaccination status of HepB and HBIG among PTB and LBW infants born to HBsAg-positive mothers. A total of 160 222 pregnant women and 159 613 live-born infants were included in this study. The estimated prevalence of PTB, LBW and HBV-infected pregnant women was 3.86% (range: 3.28%-5.10%), 2.77% (range: 2.12%-3.66%), and 3.27% (range: 3.03%-3.49%), respectively. We screened 340 PTB and LBW infants born to HBsAg-positive mothers between 2016 and 2020. We found that the coverage of HepB and HBIG among them was 100% and 99.39%. However, the timely vaccination rate of the HepB birth dose was only 78.59% and only four children (1.22%) received the 4-dose HepB as recommended by ISIV-NIP-v2016. The 4-dose of HepB for PTB and LBW infants born to HBsAg-positive mothers recommended by ISIV-NIP-v2016 was not fully implemented. A strong public health intervention should be taken to close the policy-practice gap in China in the future.
first_indexed 2024-03-11T21:40:16Z
format Article
id doaj.art-f3de3683804641a198a2161c6219955b
institution Directory Open Access Journal
issn 2164-5515
2164-554X
language English
last_indexed 2024-03-11T21:40:16Z
publishDate 2022-12-01
publisher Taylor & Francis Group
record_format Article
series Human Vaccines & Immunotherapeutics
spelling doaj.art-f3de3683804641a198a2161c6219955b2023-09-26T13:25:47ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2022-12-0118710.1080/21645515.2022.21553902155390A retrospective study of hepatitis B vaccination in preterm birth and low birth weight infants born to hepatitis B surface antigen-positive mothers: Time to close the policy-practice gapWei Qin0Yao Wang1Xiaqing Zhang2Fan Pan3Kai Cheng4Haitian Sui5Shaoyu Xie6Anhui Medical UniversityLu’an Municipal Center for Disease Control and PreventionLu’an Municipal Center for Disease Control and PreventionLu’an Municipal Center for Disease Control and PreventionLu’an Municipal Center for Disease Control and PreventionChina Biotechnology CorporationLu’an Municipal Center for Disease Control and PreventionNational Immunization Program-version 2016 (ISIV-NIP-v2016) recommended a 4-dose hepatitis B vaccine (HepB) schedule for preterm birth (PTB) and low birth weight (LBW) infants born to HBsAg-positive mothers. However, the implementation of this immunization strategy in the past five years has not been fully evaluated in China. We reviewed the data of pregnant women and live-born infants from 24 hospitals between 2016 and 2021 in Lu’an, Anhui province, to estimate the prevalence of PTB, LBW, and hepatitis B virus (HBV) infected pregnant women. We analyzed the vaccination status of HepB and HBIG among PTB and LBW infants born to HBsAg-positive mothers. A total of 160 222 pregnant women and 159 613 live-born infants were included in this study. The estimated prevalence of PTB, LBW and HBV-infected pregnant women was 3.86% (range: 3.28%-5.10%), 2.77% (range: 2.12%-3.66%), and 3.27% (range: 3.03%-3.49%), respectively. We screened 340 PTB and LBW infants born to HBsAg-positive mothers between 2016 and 2020. We found that the coverage of HepB and HBIG among them was 100% and 99.39%. However, the timely vaccination rate of the HepB birth dose was only 78.59% and only four children (1.22%) received the 4-dose HepB as recommended by ISIV-NIP-v2016. The 4-dose of HepB for PTB and LBW infants born to HBsAg-positive mothers recommended by ISIV-NIP-v2016 was not fully implemented. A strong public health intervention should be taken to close the policy-practice gap in China in the future.http://dx.doi.org/10.1080/21645515.2022.2155390hepatitis bpreterm birthlow birth weightimmunization strategyhepatitis b surface antigen-positive mother
spellingShingle Wei Qin
Yao Wang
Xiaqing Zhang
Fan Pan
Kai Cheng
Haitian Sui
Shaoyu Xie
A retrospective study of hepatitis B vaccination in preterm birth and low birth weight infants born to hepatitis B surface antigen-positive mothers: Time to close the policy-practice gap
Human Vaccines & Immunotherapeutics
hepatitis b
preterm birth
low birth weight
immunization strategy
hepatitis b surface antigen-positive mother
title A retrospective study of hepatitis B vaccination in preterm birth and low birth weight infants born to hepatitis B surface antigen-positive mothers: Time to close the policy-practice gap
title_full A retrospective study of hepatitis B vaccination in preterm birth and low birth weight infants born to hepatitis B surface antigen-positive mothers: Time to close the policy-practice gap
title_fullStr A retrospective study of hepatitis B vaccination in preterm birth and low birth weight infants born to hepatitis B surface antigen-positive mothers: Time to close the policy-practice gap
title_full_unstemmed A retrospective study of hepatitis B vaccination in preterm birth and low birth weight infants born to hepatitis B surface antigen-positive mothers: Time to close the policy-practice gap
title_short A retrospective study of hepatitis B vaccination in preterm birth and low birth weight infants born to hepatitis B surface antigen-positive mothers: Time to close the policy-practice gap
title_sort retrospective study of hepatitis b vaccination in preterm birth and low birth weight infants born to hepatitis b surface antigen positive mothers time to close the policy practice gap
topic hepatitis b
preterm birth
low birth weight
immunization strategy
hepatitis b surface antigen-positive mother
url http://dx.doi.org/10.1080/21645515.2022.2155390
work_keys_str_mv AT weiqin aretrospectivestudyofhepatitisbvaccinationinpretermbirthandlowbirthweightinfantsborntohepatitisbsurfaceantigenpositivemotherstimetoclosethepolicypracticegap
AT yaowang aretrospectivestudyofhepatitisbvaccinationinpretermbirthandlowbirthweightinfantsborntohepatitisbsurfaceantigenpositivemotherstimetoclosethepolicypracticegap
AT xiaqingzhang aretrospectivestudyofhepatitisbvaccinationinpretermbirthandlowbirthweightinfantsborntohepatitisbsurfaceantigenpositivemotherstimetoclosethepolicypracticegap
AT fanpan aretrospectivestudyofhepatitisbvaccinationinpretermbirthandlowbirthweightinfantsborntohepatitisbsurfaceantigenpositivemotherstimetoclosethepolicypracticegap
AT kaicheng aretrospectivestudyofhepatitisbvaccinationinpretermbirthandlowbirthweightinfantsborntohepatitisbsurfaceantigenpositivemotherstimetoclosethepolicypracticegap
AT haitiansui aretrospectivestudyofhepatitisbvaccinationinpretermbirthandlowbirthweightinfantsborntohepatitisbsurfaceantigenpositivemotherstimetoclosethepolicypracticegap
AT shaoyuxie aretrospectivestudyofhepatitisbvaccinationinpretermbirthandlowbirthweightinfantsborntohepatitisbsurfaceantigenpositivemotherstimetoclosethepolicypracticegap
AT weiqin retrospectivestudyofhepatitisbvaccinationinpretermbirthandlowbirthweightinfantsborntohepatitisbsurfaceantigenpositivemotherstimetoclosethepolicypracticegap
AT yaowang retrospectivestudyofhepatitisbvaccinationinpretermbirthandlowbirthweightinfantsborntohepatitisbsurfaceantigenpositivemotherstimetoclosethepolicypracticegap
AT xiaqingzhang retrospectivestudyofhepatitisbvaccinationinpretermbirthandlowbirthweightinfantsborntohepatitisbsurfaceantigenpositivemotherstimetoclosethepolicypracticegap
AT fanpan retrospectivestudyofhepatitisbvaccinationinpretermbirthandlowbirthweightinfantsborntohepatitisbsurfaceantigenpositivemotherstimetoclosethepolicypracticegap
AT kaicheng retrospectivestudyofhepatitisbvaccinationinpretermbirthandlowbirthweightinfantsborntohepatitisbsurfaceantigenpositivemotherstimetoclosethepolicypracticegap
AT haitiansui retrospectivestudyofhepatitisbvaccinationinpretermbirthandlowbirthweightinfantsborntohepatitisbsurfaceantigenpositivemotherstimetoclosethepolicypracticegap
AT shaoyuxie retrospectivestudyofhepatitisbvaccinationinpretermbirthandlowbirthweightinfantsborntohepatitisbsurfaceantigenpositivemotherstimetoclosethepolicypracticegap